Please use this identifier to cite or link to this item: http://cmuir.cmu.ac.th/jspui/handle/6653943832/63699
Title: Early and Late Virologic Failure After Virologic Suppression in HIV-Infected Asian Children and Adolescents
Authors: Weiwei Mu
Adam W. Bartlett
Torsak Bunupuradah
Kulkanya Chokephaibulkit
Nagalingeswaran Kumarasamy
Penh Sun Ly
Rawiwan Hansudewechakul
Lam Van Nguyen
Pagakrong Lumbiganon
Tavitiya Sudjaritruk
Thahira A.Jamal Mohamed
Nik Khairulddin Nik Yusoff
Khanh Huu Truong
Viet Chau Do
Moy Siew Fong
Revathy Nallusamy
Nia Kurniati
Dewi Kumara Wati
Annette H. Sohn
Azar Kariminia
Fujie Zhang
Keywords: Medicine
Issue Date: 1-Mar-2019
Abstract: BACKGROUND: Virologic failure is a major threat to maintaining effective combination antiretroviral therapy, especially for children in need of lifelong treatment. With efforts to expand access to HIV viral load testing, our understanding of pediatric virologic failure is evolving. SETTING: An Asian cohort in 16 pediatric HIV services across 6 countries. METHODS: From 2005 to 2014, patients younger than 20 years who achieved virologic suppression and had subsequent viral load testing were included. Early virologic failure was defined as a HIV RNA ≥1000 copies per milliliter within 12 months of virologic suppression, and late virologic as a HIV RNA ≥1000 copies per milliliter after 12 months following virologic suppression. Characteristics at combination antiretroviral therapy initiation and virologic suppression were described, and a competing risk time-to-event analysis was used to determine cumulative incidence of virologic failure and factors at virologic suppression associated with early and late virologic failure. RESULTS: Of 1105 included in the analysis, 182 (17.9%) experienced virologic failure. The median age at virologic suppression was 6.9 years, and the median time to virologic failure was 24.6 months after virologic suppression. The incidence rate for a first virologic failure event was 3.3 per 100 person-years. Factors at virologic suppression associated with late virologic failure included older age, mostly rural clinic setting, tuberculosis, protease inhibitor-based regimens, and early virologic failure. No risk factors were identified for early virologic failure. CONCLUSIONS: Around 1 in 5 experienced virologic failure in our cohort after achieving virologic suppression. Targeted interventions to manage complex treatment scenarios, including adolescents, tuberculosis coinfection, and those with poor virologic control are required.
URI: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85061499788&origin=inward
http://cmuir.cmu.ac.th/jspui/handle/6653943832/63699
ISSN: 19447884
Appears in Collections:CMUL: Journal Articles

Files in This Item:
There are no files associated with this item.


Items in CMUIR are protected by copyright, with all rights reserved, unless otherwise indicated.